Alemtuzumab plus oral dexamethasone, followed by alemtuzumab maintenance or allogeneic transplantation in ultra high-risk CLL: Interim analysis of a phase II study of the GCLLSG and fcgcll/MW - Stilgenbauer, S; Cymbalista, F (Blood (ASH Annual Meeting Abstracts), 2011)
et al.